EUVIMEDEUVIMED entdecken
Crossref

Pevifoscorvir sodium (ALG-000184): advancing towards a novel therapeutic for chronic hepatitis B virus

Kyongmin Kim, Muhammad Azhar Sajjad

Translational Gastroenterology and Hepatology · 2026-11 · 11 · 129-129

DOI: 10.21037/tgh-2026-0159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Gastroenterology and Hepatology, 2026-11. Verfasst von Kyongmin Kim und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kim, K., & Sajjad, M. A. (2026). Pevifoscorvir sodium (ALG-000184): advancing towards a novel therapeutic for chronic hepatitis B virus. Translational Gastroenterology and Hepatology, 11, 129-129. https://doi.org/10.21037/tgh-2026-0159

Vancouver

Kim K, Sajjad MA. Pevifoscorvir sodium (ALG-000184): advancing towards a novel therapeutic for chronic hepatitis B virus. Translational Gastroenterology and Hepatology. 2026;11:129-129. doi:10.21037/tgh-2026-0159

BibTeX
@article{Kim2026,
  author = {Kim, Kyongmin and Sajjad, Muhammad Azhar},
  title = {Pevifoscorvir sodium (ALG-000184): advancing towards a novel therapeutic for chronic hepatitis B virus},
  journal = {Translational Gastroenterology and Hepatology},
  year = {2026},
  volume = {11},
  pages = {129--129},
  doi = {10.21037/tgh-2026-0159}
}
Kostenlos starten →